key: cord-0034312-jhfuc7zk
authors: Chen, Xinchun; Zhou, Boping; Li, Meizhong; Liang, Xiaorong; Wang, Huosheng; Yang, Guilin; Hui, Wang; Le, Xiaohua
title: Reply to Tso et al
date: 2004-11-01
journal: J Infect Dis
DOI: 10.1086/424574
sha: 951c10e5d81cb3170df0bf596a063860fc1a5d60
doc_id: 34312
cord_uid: jhfuc7zk

nan

To the Editor-We appreciate the letters from Tso et al. [1, 2] that expand on our study [3] of the serologic profile of severe acute respiratory syndrome (SARS). On the basis of the findings of our study, we are certain that IgG antibody persists for at least 60 days after the onset of symptoms. This is consistent with Tso et al.'s results, which, despite the different assays used, indicate that SARS-associated coronavirus (SARS CoV) immunoglobulin titers continue to increase from 15 days to 3 months after the onset of symptoms. Interestingly, the rate of seroconversion differs in the 2 studies, with an 83% rate of seroconversion reported in our study and a 100% rate of seroconversion reported in Tso et al.'s study [2] . This may have been a consequence of the different populations of patients and of the different assays used in the studies. Tso et al. selected 62 survivors from a group of 267 patients with SARS, among whom 78% had a 4-fold increase in SARS CoV immunoglobulin or a single titer of у100 during their first 3 months of follow-up [2, 4] . This 78% rate of seroconversion in the 267 patients [4] was close to our observations of 75% on day 21 and 83% on day 60. According to several reports, the immunofluorescent assay used by Tso et al. is more sensitive than the ELISA used in our study [5] [6] [7] . Nevertheless, ELISA provides similar results and remains the most convenient and reliable test in both clinical practice and epidemiologic studies.

Natural course of severe acute respiratory syndrome-associated coronavirus immunoglobulin after infection

Persistence of physical symptoms in and abnormal laboratory findings for survivors of severe acute respiratory syndrome

Serology of severe acute respiratory syndrome: implications for surveillance and outcome

Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong

Serologic and molecular biologic methods for SARS-associated coronavirus infection

Serum antibodies detection for serological diagnosis of severe acute respiratory syndrome

Immunofluorescence assay for serologic diagnosis of SARS